Benralizumab

含有 Benralizumab 的品牌、食物注意事项以及最重要的药物相互作用。

品牌

FASENRA 30 MG/ML ENJEKSIYONLUK COZELTI ICEREN KULLANIMA HAZIR ENJEKTOR (1 ADET)条形码：8699786950047
FASENRA 30 MG/ML KULLANIMA HAZIR ENJEKSIYON KALEMI ICINDE ENJEKSIYONLUK COZELTI (1 ADET)条形码：8699786950054

食物注意事项

该活性成分暂无已收录的食物注意事项。

最重要的相互作用

前 10 项，共 50 项

Abciximab中等
当 Abciximab 与 Benralizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Abciximab is combined with Benralizumab.
Adalimumab中等
当 Adalimumab 与 Benralizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Adalimumab is combined with Benralizumab.
Adecatumumab中等
当 Adecatumumab 与 Benralizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Adecatumumab is combined with Benralizumab.
Afelimomab中等
当 Afelimomab 与 Benralizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Afelimomab is combined with Benralizumab.
Alemtuzumab中等
当 Alemtuzumab 与 Benralizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Benralizumab.
Alirocumab中等
当 Alirocumab 与 Benralizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Alirocumab is combined with Benralizumab.
AMG 108中等
当 AMG 108 与 Benralizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when AMG 108 is combined with Benralizumab.
Anifrolumab中等
当 Anifrolumab 与 Benralizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Anifrolumab is combined with Benralizumab.
Anthrax immune globulin human中等
当 Anthrax immune globulin human 与 Benralizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Anthrax immune globulin human is combined with Benralizumab.
Antilymphocyte immunoglobulin (horse)中等
当 Antilymphocyte immunoglobulin (horse) 与 Benralizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Antilymphocyte immunoglobulin (horse) is combined with Benralizumab.